Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG plus domperidone versus PEG plus placebo for chronic constipation in children with cerebral palsy
IRCT20130812014333N126Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, double-blind trial of macrogol, domperidone and Placebo-COD Research Private Ltd in chronic constipation (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Chronic constipation. Started Jul 2019; status: completed.
02
Drugs
macrogoldomperidonePlacebo-COD Research Private Ltd
03
Conditions
chronic constipation
Beyond the preview
Go deeper on IRCT20130812014333N126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N126.